Blood is a specialized body fluid. It has four main components: plasma, red blood cells, white blood cells, and platelets. Blood has many different functions, including: transporting oxygen and nutrients to the lungs and tissues.
麻豆原创 Analysis and Insights: Global Blood and Blood Components 麻豆原创
The global Blood and Blood Components market is projected to grow from US$ 30620 million in 2024 to US$ 35100 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.3% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Blood and Blood Components market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Blood and Blood Components, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Blood and Blood Components, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood and Blood Components revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Blood and Blood Components market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Blood and Blood Components revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
American Association of Blood Banks (AABB)
AVIS National
International Federation of Red Cross and Red Crescent Societies (IFRC)
NHS Blood and Transplant (NHSBT)
Northern Ireland Blood Transfusion Service
Scottish National Blood Transfusion Service(NHS National Services Scotland)
Welsh Blood Service
Segment by Type
Whole Blood
Blood Components
Segment by Application
Anemia
Trauma & Surgery
Cancer Treatment
Bleeding Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Blood and Blood Components in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood and Blood Components companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood and Blood Components revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Blood and Blood Components 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Whole Blood
1.2.3 Blood Components
1.3 麻豆原创 by Application
1.3.1 Global Blood and Blood Components 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Anemia
1.3.3 Trauma & Surgery
1.3.4 Cancer Treatment
1.3.5 Bleeding Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood and Blood Components 麻豆原创 Perspective (2019-2030)
2.2 Global Blood and Blood Components Growth Trends by Region
2.2.1 Blood and Blood Components 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood and Blood Components Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Blood and Blood Components Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Blood and Blood Components 麻豆原创 Dynamics
2.3.1 Blood and Blood Components Industry Trends
2.3.2 Blood and Blood Components 麻豆原创 Drivers
2.3.3 Blood and Blood Components 麻豆原创 Challenges
2.3.4 Blood and Blood Components 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Blood and Blood Components by Players
3.1.1 Global Blood and Blood Components Revenue by Players (2019-2024)
3.1.2 Global Blood and Blood Components Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Blood and Blood Components 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Blood and Blood Components, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Blood and Blood Components 麻豆原创 Concentration Ratio
3.4.1 Global Blood and Blood Components 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood and Blood Components Revenue in 2023
3.5 Global Key Players of Blood and Blood Components Head office and Area Served
3.6 Global Key Players of Blood and Blood Components, Product and Application
3.7 Global Key Players of Blood and Blood Components, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood and Blood Components Breakdown Data by Type
4.1 Global Blood and Blood Components Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Blood and Blood Components Forecasted 麻豆原创 Size by Type (2025-2030)
5 Blood and Blood Components Breakdown Data by Application
5.1 Global Blood and Blood Components Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Blood and Blood Components Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Blood and Blood Components 麻豆原创 Size (2019-2030)
6.2 North America Blood and Blood Components 麻豆原创 Size by Type
6.2.1 North America Blood and Blood Components 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Blood and Blood Components 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Blood and Blood Components 麻豆原创 Share by Type (2019-2030)
6.3 North America Blood and Blood Components 麻豆原创 Size by Application
6.3.1 North America Blood and Blood Components 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Blood and Blood Components 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Blood and Blood Components 麻豆原创 Share by Application (2019-2030)
6.4 North America Blood and Blood Components 麻豆原创 Size by Country
6.4.1 North America Blood and Blood Components 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Blood and Blood Components 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Blood and Blood Components 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Blood and Blood Components 麻豆原创 Size (2019-2030)
7.2 Europe Blood and Blood Components 麻豆原创 Size by Type
7.2.1 Europe Blood and Blood Components 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Blood and Blood Components 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Blood and Blood Components 麻豆原创 Share by Type (2019-2030)
7.3 Europe Blood and Blood Components 麻豆原创 Size by Application
7.3.1 Europe Blood and Blood Components 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Blood and Blood Components 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Blood and Blood Components 麻豆原创 Share by Application (2019-2030)
7.4 Europe Blood and Blood Components 麻豆原创 Size by Country
7.4.1 Europe Blood and Blood Components 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Blood and Blood Components 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Blood and Blood Components 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Blood and Blood Components 麻豆原创 Size (2019-2030)
8.2 China Blood and Blood Components 麻豆原创 Size by Type
8.2.1 China Blood and Blood Components 麻豆原创 Size by Type (2019-2024)
8.2.2 China Blood and Blood Components 麻豆原创 Size by Type (2025-2030)
8.2.3 China Blood and Blood Components 麻豆原创 Share by Type (2019-2030)
8.3 China Blood and Blood Components 麻豆原创 Size by Application
8.3.1 China Blood and Blood Components 麻豆原创 Size by Application (2019-2024)
8.3.2 China Blood and Blood Components 麻豆原创 Size by Application (2025-2030)
8.3.3 China Blood and Blood Components 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Blood and Blood Components 麻豆原创 Size (2019-2030)
9.2 Asia Blood and Blood Components 麻豆原创 Size by Type
9.2.1 Asia Blood and Blood Components 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Blood and Blood Components 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Blood and Blood Components 麻豆原创 Share by Type (2019-2030)
9.3 Asia Blood and Blood Components 麻豆原创 Size by Application
9.3.1 Asia Blood and Blood Components 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Blood and Blood Components 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Blood and Blood Components 麻豆原创 Share by Application (2019-2030)
9.4 Asia Blood and Blood Components 麻豆原创 Size by Region
9.4.1 Asia Blood and Blood Components 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Blood and Blood Components 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Blood and Blood Components 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Blood and Blood Components 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 American Association of Blood Banks (AABB)
11.1.1 American Association of Blood Banks (AABB) Company Details
11.1.2 American Association of Blood Banks (AABB) Business Overview
11.1.3 American Association of Blood Banks (AABB) Blood and Blood Components Introduction
11.1.4 American Association of Blood Banks (AABB) Revenue in Blood and Blood Components Business (2019-2024)
11.1.5 American Association of Blood Banks (AABB) Recent Developments
11.2 AVIS National
11.2.1 AVIS National Company Details
11.2.2 AVIS National Business Overview
11.2.3 AVIS National Blood and Blood Components Introduction
11.2.4 AVIS National Revenue in Blood and Blood Components Business (2019-2024)
11.2.5 AVIS National Recent Developments
11.3 International Federation of Red Cross and Red Crescent Societies (IFRC)
11.3.1 International Federation of Red Cross and Red Crescent Societies (IFRC) Company Details
11.3.2 International Federation of Red Cross and Red Crescent Societies (IFRC) Business Overview
11.3.3 International Federation of Red Cross and Red Crescent Societies (IFRC) Blood and Blood Components Introduction
11.3.4 International Federation of Red Cross and Red Crescent Societies (IFRC) Revenue in Blood and Blood Components Business (2019-2024)
11.3.5 International Federation of Red Cross and Red Crescent Societies (IFRC) Recent Developments
11.4 NHS Blood and Transplant (NHSBT)
11.4.1 NHS Blood and Transplant (NHSBT) Company Details
11.4.2 NHS Blood and Transplant (NHSBT) Business Overview
11.4.3 NHS Blood and Transplant (NHSBT) Blood and Blood Components Introduction
11.4.4 NHS Blood and Transplant (NHSBT) Revenue in Blood and Blood Components Business (2019-2024)
11.4.5 NHS Blood and Transplant (NHSBT) Recent Developments
11.5 Northern Ireland Blood Transfusion Service
11.5.1 Northern Ireland Blood Transfusion Service Company Details
11.5.2 Northern Ireland Blood Transfusion Service Business Overview
11.5.3 Northern Ireland Blood Transfusion Service Blood and Blood Components Introduction
11.5.4 Northern Ireland Blood Transfusion Service Revenue in Blood and Blood Components Business (2019-2024)
11.5.5 Northern Ireland Blood Transfusion Service Recent Developments
11.6 Scottish National Blood Transfusion Service(NHS National Services Scotland)
11.6.1 Scottish National Blood Transfusion Service(NHS National Services Scotland) Company Details
11.6.2 Scottish National Blood Transfusion Service(NHS National Services Scotland) Business Overview
11.6.3 Scottish National Blood Transfusion Service(NHS National Services Scotland) Blood and Blood Components Introduction
11.6.4 Scottish National Blood Transfusion Service(NHS National Services Scotland) Revenue in Blood and Blood Components Business (2019-2024)
11.6.5 Scottish National Blood Transfusion Service(NHS National Services Scotland) Recent Developments
11.7 Welsh Blood Service
11.7.1 Welsh Blood Service Company Details
11.7.2 Welsh Blood Service Business Overview
11.7.3 Welsh Blood Service Blood and Blood Components Introduction
11.7.4 Welsh Blood Service Revenue in Blood and Blood Components Business (2019-2024)
11.7.5 Welsh Blood Service Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
American Association of Blood Banks (AABB)
AVIS National
International Federation of Red Cross and Red Crescent Societies (IFRC)
NHS Blood and Transplant (NHSBT)
Northern Ireland Blood Transfusion Service
Scottish National Blood Transfusion Service(NHS National Services Scotland)
Welsh Blood Service
听
听
*If Applicable.
